|
Q3 FY2015
As of Sep 30, 2015
|
Q2 FY2015
As of Jun 30, 2015
|
Q1 FY2015
As of Mar 31, 2015
|
Q4 FY2014
As of Dec 31, 2014
|
Q3 FY2014
As of Sep 30, 2014
|
Q2 FY2014
As of Jun 30, 2014
|
Q1 FY2014
As of Mar 31, 2014
|
Q4 FY2013
As of Dec 31, 2013
|
Q3 FY2013
As of Sep 30, 2013
|
Q2 FY2013
As of Jun 30, 2013
|
Q1 FY2013
As of Mar 31, 2013
|
Q4 FY2012
As of Dec 31, 2012
|
Q3 FY2012
As of Sep 30, 2012
|
Q2 FY2012
As of Jun 30, 2012
|
Q1 FY2012
As of Mar 31, 2012
|
Q4 FY2011
As of Dec 31, 2011
|
Q3 FY2011
As of Sep 30, 2011
|
Q2 FY2011
As of Jun 30, 2011
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||
| Cash and due from banks | ||||||||||||||||||
| Interest-bearing bank balances | ||||||||||||||||||
| Investment certificates of deposit | ||||||||||||||||||
| Loans held for sale | ||||||||||||||||||
| Available for sale investment securities | ||||||||||||||||||
| Held to maturity investment securities (market value of $140,648 and $131,915 at September 30, 2015 and December 31, 2014, respectively) | ||||||||||||||||||
| Loans | ||||||||||||||||||
| Less allowance for credit losses | ||||||||||||||||||
| Net loans | ||||||||||||||||||
| Premises and equipment | ||||||||||||||||||
| Goodwill and other intangible assets | ||||||||||||||||||
| Goodwill | ||||||||||||||||||
| Core deposit intangible | ||||||||||||||||||
| Real estate acquired in settlement of loans | ||||||||||||||||||
| Bank-owned life insurance | ||||||||||||||||||
| Deferred tax assets | ||||||||||||||||||
| Other assets | ||||||||||||||||||
| Total assets | ||||||||||||||||||
| Liabilities | ||||||||||||||||||
| Noninterest-bearing deposits | ||||||||||||||||||
| NOW deposits | ||||||||||||||||||
| Savings and money market deposits | ||||||||||||||||||
| Time deposits | ||||||||||||||||||
| Total deposits | ||||||||||||||||||
| Federal Home Loan Bank borrowings | ||||||||||||||||||
| Other borrowings | ||||||||||||||||||
| Accrued expenses and other liabilities | ||||||||||||||||||
| Total liabilities | ||||||||||||||||||
| Shareholders' Equity | ||||||||||||||||||
| Preferred stock - Authorized 30,000,000 shares; issued and outstanding - none at 9/30/2015 and 12/31/2014 | ||||||||||||||||||
| Preferred Stock Series A | ||||||||||||||||||
| Preferred Stock Series B | ||||||||||||||||||
| Preferred Stock Series C | ||||||||||||||||||
| Total preferred stock - Authorized 30,000,000 shares; issued and outstanding - none at 9/30/2015 and 12/31/2014 | ||||||||||||||||||
| Common stock: Class A and Class B | ||||||||||||||||||
| Paid-in capital | ||||||||||||||||||
| Directors' deferred compensation plan | ||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||
| Shareholders’ equity | ||||||||||||||||||
| Preferred Stock Series A | ||||||||||||||||||
| Preferred Stock Series B | ||||||||||||||||||
| Preferred Stock Series C | ||||||||||||||||||
| Total shareholders’ equity | ||||||||||||||||||
| Total liabilities and shareholders’ equity | ||||||||||||||||||
Loading...
